2024
|
P/S
|
Pharmaceutical preparations for the treatment of liver diseases.. |
2023
|
P/S
|
Pharmaceutical preparations for the treatment of diabetes; pharmaceutical preparations for weight... |
|
P/S
|
Pharmaceutical preparations for the treatment of diabetes;
pharmaceutical preparations for weigh... |
|
P/S
|
Pharmaceutical preparations for the treatment of diabetes; Pharmaceutical preparations for weight... |
|
P/S
|
Downloadable software applications for use with diabetes management Medical information services ... |
|
P/S
|
Downloadable materials, namely, educational videos, podcasts, multimedia files, audio, images, an... |
|
Invention
|
Solid compositions comprising a glp-1 agonist and a salt of n-(8-(2-hydroxybenzoyl)amino)caprylic... |
|
P/S
|
Pharmaceutical preparations for the treatment and prevention of hypoglycemia; medical preparation... |
|
Invention
|
Prodrugs and uses thereof.
Prodrug compounds of GLP-1/GIP receptor co-agonists are provided wher... |
|
Invention
|
Semaglutide for use in medicine.
The present invention is directed to use of the GLP-1 receptor ... |
|
P/S
|
Waste collection, waste storage, waste removal Waste treatment, waste recycling services |
|
P/S
|
Waste collection, waste storage, waste removal. Waste treatment, waste recycling services. |
|
Invention
|
A sirp-alpha binding chimeric protein. The present disclosure provides chimeric proteins comprisi... |
|
Invention
|
Pharmaceutical composition comprising mineralocorticoid receptor antagonist and use thereof.
Pro... |
|
P/S
|
Downloadable software applications for use with diabetes management. Medical information services... |
|
Invention
|
Factor x binders enhancing fx activation.
The application relates to unique FX binding molecules... |
|
P/S
|
Pharmaceutical preparations for the treatment of liver diseases. |
|
Invention
|
Novel anti-angptl3 antibodies suitable for high concentration compositions and subcutaneous admin... |
|
Invention
|
Ingestible device with rotational trigger release. A capsule device (100.2) suitable for ingestio... |
|
Invention
|
Ingestible device with rotational drive mechanism. A capsule device (100.1) suitable for ingestio... |
|
P/S
|
Enzymes for industrial purposes. |
|
P/S
|
Enzymes for industrial purposes |
|
P/S
|
Enzymes for industrial purposes. |
|
Invention
|
Compositions of glp-1 peptides and preparation thereof.
The invention relates to pharmaceutical ... |
|
Invention
|
Glp-1 compositions and uses thereof.
The present invention relates to pharmaceutical composition... |
|
Invention
|
Highly potent isvd compounds capable of substituting for fviii(a).
The present invention provide... |
|
Invention
|
Highly potent isvd compounds capable of substituting for fviii(a). The present invention provides... |
|
Invention
|
Differentiation of stem cells to pancreatic endocrine cells. in vitroin vitro method for producin... |
|
Invention
|
Enhancing neuronal differentiation of ventral midbrain neural progenitor cells. The present inven... |
|
P/S
|
Educational services, namely, conducting educational programs, developing education manuals; prov... |
|
Invention
|
Compositions and methods for inhibiting transmembrane serine protease 6 (tmprss6) expression. Oli... |
|
Invention
|
Systems and methods for regimen adherence evaluation. A diabetes management system adapted to det... |
|
P/S
|
Pharmaceutical preparations. |
|
Invention
|
Glucose-sensitive albumin-binding derivatives.
This invention relates to glucose-sensitive album... |
|
Invention
|
An applicator system and a blister package for the applicator system. The present invention relat... |
|
P/S
|
Downloadable podcasts and downloadable written articles and video recordings on the subject of he... |
|
Invention
|
Selective elimination of erosive cells.
The current invention relates to the treatment of diseas... |
|
P/S
|
Pharmaceutical preparations for the treatment of neurodegenerative disorders and diseases |
|
Invention
|
Drug delivery device with adapted to prevent an unintended dose. A drug delivery device (300) com... |
|
Invention
|
Prodrugs of glp-1 polypeptide and uses thereof. The invention relates to DKP-based prodrugs from ... |
|
Invention
|
Anti-angptl3 antibodies suitable for high concentration compositions and subcutaneous administrat... |
|
Invention
|
Dose logging device with scale drum scanner. A drug delivery device comprising a housing with an ... |
|
Invention
|
Compositions and methods for inhibiting mitochondria amidoxime reducing component 1 (marc1) expre... |
|
Invention
|
Formulation method. Disclosed herein is a method of co-formulating an amylin receptor agonist and... |
2022
|
Invention
|
Mic-1 compounds and uses thereof.
The invention relates to MIC-1 compounds. More specifically it... |
|
Invention
|
Co-agonists of the glp-1 and amylin receptors.
The invention relates to a compound comprising a ... |
|
Invention
|
Propylene glycol-containing peptide formulations which are optimal for production and for use in ... |
|
Invention
|
Drug delivery device for delivering a predefined fixed dose.
1. A drug delivery device for deliv... |
|
Invention
|
Drug delivery device for delivering a predefined fixed dose.
A drug delivery device (100, 300) f... |
|
Invention
|
Drug delivery device for delivering a predefined fixed dose.
A drug delivery device (100, 300), ... |
|
Invention
|
A torsion spring driven fixed dose injection device.
The invention relates to a medical injectio... |
2021
|
Invention
|
Fast data transmission feature for medical logging device.
A drug delivery device comprising ele... |
|
Invention
|
Compounds and their use in treatment of tachykinin receptor mediated disorders.
The present inve... |
|
Invention
|
Substance delivering capsule.
1. A capsule device (100) suitable for swallowing into a lumen of ... |
|
Invention
|
Dose logging sensor system with error detection feature.
A drug delivery system comprising drug ... |
|
Invention
|
Glp-1, gip and glucagon receptor triple agonists.
The invention relates to peptides and derivati... |
|
Invention
|
Anti-transthyretin antibodies and methods of use thereof.
Provided herein are methods and compos... |
|
Invention
|
Capsule device.
A capsule device (100) suitable for insertion or ingestion into a lumen, such as... |
|
Invention
|
Device for intestinal drug delivery.
An ingestible jet injection device for introducing a fluid ... |
|
Invention
|
A swallowable capsule device.
The swallowable capsule device (10) comprises a capsule housing (1... |
|
Invention
|
A swallowable capsule device.
A capsule device (10) suitable for swallowing into a lumen of an i... |
|
Invention
|
Lumen insertable capsule.
A capsule device (100) suitable for insertion into a lumen, such as a ... |
|
Invention
|
Method for screening in vitro population of stem cell derived beta like cells and novel markers t... |
|
Invention
|
Glp-1 and gip receptor co-agonists.
Peptide co-agonists of the human GLP-1 and GIP receptors, lo... |
|
Invention
|
Use of pluripotent markers to detect contaminating residual undifferentiated pluripotent stem cel... |